Stocks and Investing Stocks and Investing
Mon, May 13, 2024

Raghuram Selvaraju Maintained (VRNA) at Strong Buy with Decreased Target to $30 on, May 13th, 2024


Published on 2024-10-28 11:18:39 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Decreased Target from $33 to $30 on, May 13th, 2024.

Raghuram has made no other calls on VRNA in the last 4 months.



There are 2 other peers that have a rating on VRNA. Out of the 2 peers that are also analyzing VRNA, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Yasmeen Rahimi of "Piper Sandler" Maintained at Buy with Increased Target to $36 on, Tuesday, April 16th, 2024
  • Liana Moussatos of "Wedbush" Reiterated at Buy and Held Target at $33 on, Friday, March 1st, 2024
Contributing Sources